Moller D E, Yokota A, Ginsberg-Fellner F, Flier J S
Charles A. Dana Research Institute, Department of Medicine, Beth Israel Hospital, Boston, Massachusetts 02215.
Mol Endocrinol. 1990 Aug;4(8):1183-91. doi: 10.1210/mend-4-8-1183.
Based on the sequence of cDNA encoding the intracellular domain of the insulin receptor beta-subunit, we recently defined a heterozygous point mutation causing a Ser for Trp substitution at position 1200 in the tyrosine kinase domain of a patient (BI-2) with the type A syndrome of insulin resistance. We have now sequenced the remainder of BI-2's insulin receptor cDNA-coding region and find no additional alterations in the encoded proreceptor protein. The nucleotide sequence of cDNA encoding the portion of the beta-subunit which includes Trp1200 was normal in BI-2's unaffected mother. Hybridization of a mutant allele-specific oligonucleotide to polymerase chain reaction-amplified cDNA confirmed the presence of the mutant allele in the proband and excluded it in her unaffected sister and mother, 18 normal control subjects, and six other subjects with insulin resistance. To determine whether this mutation had functional consequences for receptor signalling, we reconstructed it into a full-length insulin receptor cDNA expression vector. Chinese hamster ovary cells were transfected with mutant cDNA, and the expressed insulin receptors were compared to receptors expressed by cells transfected with wild-type receptor cDNA. Both mutant and wild-type receptors were properly processed into receptor alpha- and beta-subunits, were expressed on the cell surface, and displayed similar insulin-binding affinity. In contrast, insulin-stimulated autophosphorylation of the mutant receptors was severely impaired, whether assessed in intact cells or with a partially purified receptor preparation.(ABSTRACT TRUNCATED AT 250 WORDS)
基于编码胰岛素受体β亚基细胞内结构域的cDNA序列,我们最近确定了一个杂合点突变,该突变导致一名患有A型胰岛素抵抗综合征的患者(BI-2)酪氨酸激酶结构域第1200位的丝氨酸被色氨酸取代。我们现已对BI-2胰岛素受体cDNA编码区的其余部分进行了测序,发现编码的前受体蛋白没有其他改变。在BI-2未受影响的母亲中,编码包含色氨酸1200的β亚基部分的cDNA核苷酸序列是正常的。突变等位基因特异性寡核苷酸与聚合酶链反应扩增的cDNA杂交,证实先证者中存在突变等位基因,并在其未受影响的姐妹和母亲、18名正常对照受试者以及其他6名胰岛素抵抗受试者中排除了该突变等位基因。为了确定该突变是否对受体信号传导有功能影响,我们将其构建到全长胰岛素受体cDNA表达载体中。用突变cDNA转染中国仓鼠卵巢细胞,并将表达的胰岛素受体与用野生型受体cDNA转染的细胞所表达的受体进行比较。突变型和野生型受体都能正确加工成受体α亚基和β亚基,在细胞表面表达,并表现出相似的胰岛素结合亲和力。相比之下,无论是在完整细胞中还是用部分纯化的受体制剂进行评估,胰岛素刺激的突变受体自身磷酸化都严重受损。(摘要截短于250字)